Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) was the recipient of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 2,140,000 shares, a growth of 59.7% from the January 31st total of 1,340,000 shares. Currently, 3.8% of the company's stock are sold short. Based on an average trading volume of 301,800 shares, the days-to-cover ratio is presently 7.1 days.
HYPR opened at $0.97 on Friday. The business has a 50 day moving average price of $1.06 and a 200 day moving average price of $1.02. Hyperfine has a twelve month low of $0.76 and a twelve month high of $1.90. The firm has a market cap of $70.76 million, a P/E ratio of -1.70 and a beta of 0.92.
Large investors have recently modified their holdings of the business. Geode Capital Management LLC raised its holdings in Hyperfine by 18.7% in the 3rd quarter. Geode Capital Management LLC now owns 624,520 shares of the company's stock valued at $675,000 after acquiring an additional 98,335 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of Hyperfine by 32.9% in the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company's stock valued at $187,000 after purchasing an additional 52,500 shares in the last quarter. Graypoint LLC acquired a new position in shares of Hyperfine in the 4th quarter valued at $44,000. Finally, Virtu Financial LLC acquired a new position in shares of Hyperfine in the 4th quarter valued at $25,000. 15.03% of the stock is currently owned by institutional investors and hedge funds.
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hyperfine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.
While Hyperfine currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.